Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
472
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
KKR to invest in Precipart Group Ltd.
Private Equity | Healthcare | Industrial Machinery & Components

KKR to invest in Precipart Group Ltd.

Kohlberg Kravis Roberts (KKR) has agreed to make a significant strategic investment in Precipart Group Ltd., a leading contract manufacturer of precision components for the medical device and aerospace industries. KKR plans to support the company in its continued growth organically and through M&A.

Learn more
TDK Corporation has divested its medical business HTI Medical to GTCR-backed Resonetics
Private Equity | Healthcare

TDK Corporation has divested its medical business HTI Medical to GTCR-backed Resonetics

Hutchinson Technology, Inc., a subsidiary of TDK Corporation, has sold its medical business HTI Medical to Resonetics, a portfolio company of GTCR.

Learn more
Vascotube GmbH has been acquired by Cirtec Medical Systems, LLC
Healthcare | Private Equity

Vascotube GmbH has been acquired by Cirtec Medical Systems, LLC

Ordito GmbH, a private investment company, has sold Vascotube GmbH, a leading German manufacturer of high quality nitinol tubing, to 3i-backed Cirtec Medical Systems, LLC (Cirtec), a provider of design and contract manufacturing services for implantable and minimally invasive surgical devices. Financial details will remain confidential.

Learn more
“My team, my family and I are thrilled to form this strategic partnership with KKR, who are the right partners to help take Precipart to the next level. The Oaklins team has been instrumental in concluding the transaction with our partner of choice. We have appreciated their high level of commitment, professionalism and guidance through the whole process.”

Oliver Laubscher

Member of the Board and CEO, Precipart Group Ltd.

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=US&includes=featured_images,tags&language=en&limit=1&tags=healthcare

Reshaping industries: M&A highlights and strategic vision

QUARTERLY M&A ACTIVITY: The second quarter of 2024 marked a dynamic period for Oaklins with 62 closed transactions. This activity underscores the adaptability of various industries to evolving market conditions and strategic imperatives.

Learn more

Talk to our local specialists

Michael S. Goldman

Managing Director
New York, United States
Oaklins TM Capital

Meet our global industry specialists

Antoine Lemaire

Partner
Paris, France
Oaklins France

Robert Boersma

Partner
Amsterdam, Netherlands
Oaklins Netherlands

Dino Theodorou

Director
Johannesburg, South Africa
Oaklins Grindrod

Stuart Goodman

Partner
London, United Kingdom
Oaklins Evelyn Partners

Michael Jewell

Partner
London, United Kingdom
Oaklins Cavendish